Rhonda Patrick· PhD
where the the rubber really meets the road is in metabolic disease because it's only when you're insulin resistant that having elevated lps is an issue
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
where the the rubber really meets the road is in metabolic disease because it's only when you're insulin resistant that having elevated lps is an issue
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so i wonder if we should be focusing less on lps because we're always going to have some and it's always going to go up intermittently and if we just actually do the things that we know work to improve insulin resistance then that's really gonna solve the issue